| PRD_000939 | Name: | modified protein phyllopod peptide BI-117E1 | Formula: | C70 H131 N23 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
| PRD_000942 | Name: | modified protein phyllopod peptide BI-117C3 | Formula: | C79 H137 N25 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
| PRD_000943 | Name: | Protein phyllopod | Formula: | C74 H138 N24 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
| PRD_001070 | Name: | bacitracin A2 | Formula: | C66 H106 N17 O16 S | Definition date: | 2013-08-14 | Last modified: | 2013-08-14 |
|
| PRD_001133 | Name: | (2R,6S,13aR,14aR,16aS)-6-{[(cyclopentyloxy)carbonyl]amino}-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate | Formula: | C37 H51 N5 O9 S | Definition date: | 2013-08-07 | Last modified: | 2020-07-20 |
|
| PRD_001138 | Name: | (3S,7R,8aR)-2-{(2S)-2-(4,4-difluorocyclohexyl)-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-7-ethoxyoctahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C31 H45 F2 N5 O5 | Definition date: | 2013-08-07 | Last modified: | 2017-09-14 |
|
| PRD_001139 | Name: | (3S,8aR)-2-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | Formula: | C30 H45 N5 O3 | Definition date: | 2013-08-07 | Last modified: | 2017-09-14 |
|
| PRD_002097 | Name: | [[[(4S)-5-[[(2S)-1-[[(2S)-5-[[azaniumylidene(azanyl)methyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanylidene-4-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoylamino]pentyl]amino]-azanyl-methylidene]azanium | Formula: | C27 H46 N10 O6 | Description: | Acts as a reversible inhibitor of serine/cysteine proteases and some trypsin-like serine proteases. | Definition date: | 2013-08-07 | Last modified: | 2022-10-20 |
|
| PRD_002098 | Formula: | C29 H43 N10 O9 | Definition date: | 2013-08-07 | Last modified: | 2023-11-03 |
|
| PRD_000894 | Name: | MM-102 | Formula: | C35 H50 F2 N7 O4 | Definition date: | 2013-07-31 | Last modified: | 2023-11-03 |
|
| PRD_000895 | Name: | MM-101 | Formula: | C35 H52 N7 O4 | Definition date: | 2013-07-31 | Last modified: | 2023-11-03 |
|
| PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
| PRD_000970 | Name: | Synthetic peptide LR | Formula: | C43 H72 N13 O13 S | Definition date: | 2013-07-24 | Last modified: | 2013-07-24 |
|
| PRD_000926 | Name: | bicyclic peptide UK18-D-Ser, uPA inhibitor | Formula: | C78 H124 N27 O25 S3 | Definition date: | 2013-07-17 | Last modified: | 2013-07-17 |
|
| PRD_000927 | Name: | bicyclic peptide UK18-D-Aba inhibitor of uPA | Formula: | C79 H126 N27 O24 S3 | Definition date: | 2013-07-17 | Last modified: | 2013-07-17 |
|
| PRD_001127 | Name: | GRAMICIDIN A | Formula: | C103 H140 N20 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-10 | Last modified: | 2013-07-10 |
|
| PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
| PRD_001128 | Name: | GRAMICIDIN C | Formula: | C101 H139 N19 O18 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
| PRD_001129 | Name: | Microcin C7 analog | Formula: | C28 H51 N12 O11 S | Definition date: | 2013-07-01 | Last modified: | 2013-07-01 |
|
| PRD_000909 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | Formula: | C25 H42 B N3 O6 | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
| PRD_000935 | Name: | N-[(benzyloxy)carbonyl]-6-diazonio-5-oxo-L-norleucyl-L-valyl-L-prolyl-L-leucine | Formula: | C30 H43 N6 O8 | Definition date: | 2013-06-26 | Last modified: | 2023-11-03 |
|
| PRD_001126 | Name: | Microcin C7 ANALOG | Formula: | C28 H51 N12 O11 Se | Definition date: | 2013-06-26 | Last modified: | 2013-06-26 |
|
| PRD_001122 | Name: | CYCLOSPORIN D | Formula: | C64 H115 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|
| PRD_001123 | Name: | CYCLOSPORIN C | Formula: | C64 H114 N10 O14 | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | Definition date: | 2013-06-20 | Last modified: | 2013-06-20 |
|